iX Biopharma Ltd announced on Feb, 13 2026 that it has issued 1,049,650 new ordinary shares following the exercise of warrants at 0.06 Singapore dollars per share.

The allotment lifts the company’s total issued share capital to 960,493,895 shares from 959,444,245 previously. The newly issued shares will rank pari passu with existing shares and are expected to start trading on the Singapore Exchange on or about Feb, 19 2026.

To date, holders have exercised 5,534,450 warrants—representing 9.62% of the warrants originally issued—leaving 51,975,029 outstanding warrants. These remaining warrants carry an exercise price of 0.06 Singapore dollars per share and expire on Jul, 18 2026.

Warrant holders can find exercise instructions on the company’s website.